National focal points contact information

On this page, you can find contact information for the EMCDDA's national focal points, including the Reitox network of focal points.

Select a country from the list below.

Austria

About our partner in Austria

The national focal point is located within the Austrian Public Health Institute (Gesundheit Österreich GmbH), a public body funded by the Federal Ministry of Health. The Austrian Public Health Institute has three business units, carrying out research, planning, monitoring and reporting activities (within the business unit ÖBIG), developing, implementing and evaluating a nationwide quality system for healthcare (within the business unit BIQG) and promoting and financing health promotion activities (within the business unit FGÖ). The national focal point is part of the Addiction Competence Center established at ÖBIG.

Austrian Public Health Institute (Gesundheit Österreich GmbH, GÖG)

Stubenring 6
(Biberstrasse 20 for parcels and normal mail)
A-1010 Wien
Tel. +43 151561131
Fax +43 5138472
Head of national focal point: Ms Ilonka Horvath

Additional resources submitted by our partner

The Report on the Drug Situation in Austria primarily deals with the illicit drug situation and serves as both a national report to the Austrian Federal Ministry of Health and Women’s Affairs and as Austria's contribution to the report on the drug situation in the European Union (English version; German version).

Click here for more information about Austria

top of page

Belgium

About our partner in Belgium

The national focal point is located within the Epidemiology Unit of the Scientific Institute of Public Health (WIV-ISP). The WIV-ISP is a state (federal) scientific organisation and implements policies in response to the legal framework and priorities of the Federal Minister for Health and the President of the Federal Public Service for Health, Food Chain Security and the Environment. The WIV-ISP is the scientific reference in the field of public health. WIV-ISP supports health policy and policy-making through innovative research, analyses, monitoring activities and expert advice. In this way, WIV-ISP contributes to a healthy life for all. The main tasks of the drugs programme of the WIV-ISP include the monitoring, collection, analysis and dissemination of drug-related information. In order to dispose of national drug-related data, cooperation and coordination with 4 regional partner organisations is vital due to the assigned responsibilities regarding health policy.

Scientific Institute of Public Health

Logo of the Belgian National Focal Point

(Institut scientifique de santé publique/Wetenschappelijk Instituut Volkgezondheid)
Rue Juliette Wytsman 14
B-1050 Bruxelles/Brussels
Belgium
Tel. +32 26425034
Fax +32 26425001
Head of national focal point: Ms Lies Gremeaux

Additional resources submitted by our partner

The latest annual national report on the in-depth analysis of the TDI data collection 2016 (Dutch version; French version).
Registration of patients with substance use disorders is of key importance to get insights and to study trends in patients characteristics and substance use patterns. In Belgium, this registration started at national level in 2011 and an increasing number of facilities of different types are participating in this data collection since then. The objective of the paper is to facilitate the use of data by authorities or researchers by correctly describing all aspects of the indicator, including strengths and limitations of the register and future improvements (download).
Feasibility study on the establishment of drug consumption rooms in Belgium, to provide an up-to-date overview of the effectiveness, models, and barriers of DCRs worldwide, with particular attention to DCRs in Belgium’s four neighbouring countries; to conduct an in-depth analysis of the legal framework within a DCR could operate in Belgium; and to conduct a feasibility study with local stakeholders and PWUD from each of the five cities.
The main objective of this research was to gain a good insight into a subject that has been rarely studied in Belgium, namely the content and the evaluation methods of good and promising  practices aimed at the social prevention of drug-related crime in Brussels,  Flanders and Wallonia.  Next to the mechanisms and predispositions An emphasis was put on how entities work together as well as the mechanism to make a project work to reach their objectives.
VAD is the Flemish expertise center for Alcohol and other Drugs. This also includes psychactive medication, gambling and gaming. In addition, VAD also serves as one of the “subfocal points”  to the Reitox National focal point.
Eurotox asbl is a socio-epidemiological observatory in Wallonia and Brussels, and also serves as one of the "subfocal points” to the Reitox National focal point.
The Mental Health Consultation Platform of the Brussels Capital Region is a consultative body for the development and organization of consultation between psychiatric institutions and services within this Region. The platform also serves as one of the “subfocal points” to the Reitox National focal point.

Click here for more information about Belgium

top of page

Bulgaria

About our partner in Bulgaria

The national focal point (NFP) is based in the National Centre for Addictions. The unit carries out informational, analytical, scientific research, expert-consultative and publishing activities. The main objectives of NFP activities include methodological control, collection, evaluation and classification, processing, storage, analysis and dissemination of information in the field of drug demand and supply in Bulgaria, drug policy and the response to the situation in that field. The NFP works on the provision of information, supporting the activity of the National Drug Council and the formulation of a state policy towards drugs and drug addiction.

National Centre for Addictions

117, Pirotska Str.
BG-1303 Sofia
Bulgaria
Tel.: +359 28313079
Fax.: +359 28321047
Head of national focal point: Mr Alexander Panayotov

Additional resources submitted by our partner

Main quantitative data on the drug use, traffic and distribution, as well as on the drug related responses in Bulgaria (download).

Click here for more information about Bulgaria

top of page

Croatia

About our partner in Croatia
 

The national focal point is located within the Office for Combating Drug Abuse of the Government of the Republic of Croatia. This Office develops drug policy and coordinates the activities of the ministries and other actors involved in the implementation of the national drug strategy at the political level. It monitors the drug situation in Croatia and proposes measures to address drug-related issues.

Government of the Republic of Croatia - Office for Combating Drug Abuse

Preobraženska 4/II
HR - 10 000 Zagreb
Croatia
Tel.: +385 14878128
Fax.: +385 14878120
Head of national focal point: Ms Lidija Vugrinec

Additional resources submitted by our partner

Click here for more information about Croatia

top of page

Cyprus

About our partner in Cyprus

The national focal point was created in March 2004 by the Cyprus Anti-Drugs Council, the main coordinating body responsible for drug and alcohol policy in Cyprus. The primary role of the national focal point is the collection, analysis and evaluation of information and data concerning the drug use situation in Cyprus and the implementation of EMCDDA activities and other related national activities.

Cyprus Anti-Drugs Council - Cyprus National Monitoring Centre for Drugs and Drug Addiction

Logo of the Cyprus National Focal Point

Cyfield Tower, Limassol Avenue 130
City Home 81, 4th floor
2015 Strovolos
CY - Nicosia, Cyprus
Tel.: +357 22442973
Fax.: +357 22305022
Head of national focal point: Ms Ioanna Yiasemi

Additional resources submitted by our partner

[Description and link(s) if applicable]
[Description and link(s) if applicable]
[Description and link(s) if applicable]
[Description and link(s) if applicable]
[Description and link(s) if applicable]
[Description and link(s) if applicable]
[Description and link(s) if applicable]
[Description and link(s) if applicable]

Click here for more information about Cyprus

top of page

Czech-Republic

About our partner in the Czech Republic

The national focal point was established as the National Monitoring Centre for Drugs and Drug Addiction in 2002, within the structure of the Office of the Government of the Czech Republic, Secretariat of the Council of the Government for Drug Policy Coordination. The main objectives of the national focal point are to monitor the situation in the field of use of psychotropic substances, prepare documentation for evidence-based decision-making at the national and European level and evaluate the efficiency of such actions. In 2014, in line with the goals of the integrated drug policy, the national focal point became responsible for data collection and analysis in the field of gambling and was renamed the National Monitoring Centre for Drugs and Addictions.

National Monitoring Centre for Drugs and Addictions

Secretariat of the Council of the Government for Drug Policy Coordination, Office of the Government of the Czech Republic
Nabr. Edvarda Benese 4
118 01 Praha 1 - Malá Strana
Czech Republic
Tel. +420 224002111
Head of national focal point: Mr Viktor Mravcik

Additional resources submitted by our partner

Click here for more information about Czech-Republic

top of page

Denmark

About our partner in Denmark

The national focal point is located within the Danish Health Authority, an autonomous Government agency linked to the Ministry of Health. The Danish Health Authority is made up of a number of divisions and centres, each dealing with its own area of expertise

Danish Health Authority

Axel Heides Gade 1
DK- 2300, Copenhagen S
Denmark
Tel. +45 72227757
Fax +45 72227411
Head of national focal point: Ms Kari Grasaasen

Click here for more information about Denmark

top of page

Estonia

About our partner in Estonia

The national focal point is located within the Infectious Disease and Drug Monitoring Department of the NIHD. The department collects, harmonises and analyses data on illicit drugs in Estonia, and disseminates information and cooperates with EU and non-EU national focal points, and other international bodies and organisations

National Institute for Health Development (NIHD) — Infectious Diseases and Drug Abuse Prevention Department

Hiiu 42
EE-11619 Tallinn
Estonia
Tel. +372 6593826
Fax +372 6593901
Head of national focal point: Ms Katri Abel-Ollo

Additional resources submitted by our partner

Click here for more information about Estonia

top of page

Finland

About our partner in Finland

The national focal point is hosted by the National Institute for Health and Welfare (THL).

National Institute for Health and Welfare (THL)

PO Box 30
FI-00271 Helsinki
(Office: Mannerheimintie 166, FI-00271 Helsinki)
Finland
Tel. ++358 295247369
Head of national focal point: Ms Sanna Rönkä

Additional resources submitted by our partner

Yearbook of Alcohol and Drug Statistics 2017. The Yearbook of alcohol and drug statistics offers an essential knowledge base for alcohol-policy decision-making and planning. It also helps experts in social and health care in assessing and studying the alcohol and drug situation in Finland. The Yearbook of alcohol and drug statistics 2017 provides key statistical information on the alcohol and drug situation in Finland. It also contains information on alcohol beverage consumption in other countries (Finnish, Swedish, English)
Drug Treatment Information System. Summary and report to publication Drug clients in drug and alcohol services (in Finnish).
Wastewater studies in Finland. Introduction, data and links to publications (Page in Finnish)
Article: Hakkarainen P & Karjalainen K. Pilvee, pilvee. Kannabiksen käyttötavat, käyttäjät ja poliittiset mielipiteet [Cannabis: use habits, users and public opinion on policy]. Yhteiskuntapolitiikka 2017; 82: 19–32. (In Finnish with English Summary).
Article: Cross-sectional study on OST clients - Detoxification and substitution in the treatment of opioid addicts in Finland has become more widespread and varied (in Finnish, paywall)

Click here for more information about Finland

top of page

France

About our partner in France

Since 1996, the French Monitoring Centre for Drugs and Drug Addiction (Observatoire français des drogues et des toxicomanies, OFDT) has been entrusted, as an independent body, with the coordination of all drug- monitoring activities in France, and has acted as the national focal point. The OFDT is also responsible for the evaluation of drug policies in France. Since 1999, its areas of activity have included licit substances (alcohol, tobacco and medicines) in addition to illicit drugs and addictive behaviours. The OFDT is mainly funded by the Inter-ministerial Mission for Combating Drugs and Addictive Behaviours (Mission interministérielle de lutte contre les drogues et les conduites addictives, MILDECA), an inter-departmental body composed of representatives of different ministries, which is responsible for the overall coordination of activities against drugs and drug dependency in France. For a comprehensive picture of the French drug situation, please refer to the national report 2016 to the EMCDDA

Observatoire français des drogues et des toxicomanies

(French Monitoring Centre for Drugs and Drug Addiction)

3, Avenue du Stade de France
F-93218 Saint Denis la Plaine Cedex
France
Tel. +33 141627716
Fax. +33 141627700
Head of national focal point: Mr Julien Morel d'Arleux

Additional resources submitted by our partner

The National Authority for Health held a public hearing on care strategies against drug abuse, addictions and polydrug use and issued recommendations. The objectives of this public hearing were to sensitize all professionals involved in the management of various addictions to the issue of polyconsumption and the need for open-ended care; to offer these professionals operational recommendations; and to propose studies, programs and training to put in place
These recommendations from the National Authority for Health aim to improve the health care of cocaine users by: facilitating their identification; describing medico-psycho-social management strategies that facilitate cessation of use and abstinence.
The National Agency for the Quality Assessment of Health and Social Care Organizations and Services issued recommendations corresponding to the regulatory missions of the CAARUD harm reduction facilities. They identify good professional practices for reception, access to harm reduction equipment and the adoption of safer practices by drug users.
A virtual village dedicated to addictions: alcohol, drugs, gambling,etc. Each virtual house is aimed at a specific audience: prevention, public authorities, users and patients, families, patient associations, companies, health professionals, research, media. This tool is very comprehensive, sharing the data of 60 actors in the field of addictions.

Click here for more information about France

top of page

Germany

About our partner in Germany

Following the establishment of the EMCDDA in 1993, the German Ministry for Health nominated the Federal Centre for Health Education (Bundeszentrale für gesundheitliche Aufklärung (BZgA), Cologne), the German Centre for Addiction Issues (Deutsche Hauptstelle für Suchtfragen e.V. (DHS), Hamm) and the IFT Institute for Therapy Research (IFT Institut für Therapiefoschung, Munich) to act jointly as the German national focal point (NFP) within the Reitox network of the EMCDDA. Together, the three institutions form the German Monitoring Centre for Drugs and Drug Addiction (DBDD) with the IFT as the institution responsible for the overall management of the NFP. Within the DBDD, the BZgA deals with prevention aspects, the DHS is mainly responsible for the working areas of addiction treatment and the IFT is responsible for epidemiology, drug policy, legal framework information, information on drug-related harms and harm reduction and the Early Warning System (EWS).

German Monitoring Centre for Drugs and Drug Addiction

(Deutsche Beobachtungsstelle für Drogen und Drogensucht, DBDD)
Leopoldstr. 175
D-80804 Müchen
Tel. +49 8936080440/41
Head of national focal point: Mr Tim Pfeiffer-Gerschel

Click here for more information about Germany

top of page

Greece

About our partner in Greece

The Greek national focal point is located within the University Mental Health Research Institute and operates as the National Centre of Documentation and Information on Drugs. The national focal point operates on the basis of a three-year contract with the Ministry of Health and collaborates with OKANA (the Greek Organisation Against Drugs). Overall, the national focal point deals with drug-related issues in the field of epidemiology and responses, and is given a mandate beyond the implementation of EMCDDA-related activities. Its responsibilities also include monitoring alcohol use and related problems, and drafting the Greek National report on drugs, the annual Greek bibliography on drugs and alcohol, and other alcohol-related assignments.

University Mental Health Research Institute

Soranou tou Efesiou, 2
(PO Box 66 517)
GR-15601 Athens
Greece
Tel. +30 2106536902
Fax +30 2106537273
Head of national focal point: Ms Manina Terzidou

Additional resources submitted by our partner

Click here for more information about Greece

top of page

Hungary

About our partner in Hungary

The Hungarian national focal point has been located within the National Institute for Health Development since 1 January 2016. Its legal basis was confirmed by an adoption of a governmental resolution in September 2003. The Inter-ministerial Coordination Committee on Drug Affairs oversees the work of the national focal point.

National Institute for Health Development

Albert Florian str. 2 - 6
H-1097 Budapest
Hungary
Tel. +36 1 476 11 00
Head of national focal point: Mr Gergely Horváth

Additional resources submitted by our partner

Click here for more information about Hungary

top of page

Ireland

About our partner in Ireland

The Irish national focal point is located in the Health Research Board (HRB). The HRB is a statutory body with a mission to improve health through research and information. The HRB is responsible for promoting, commissioning and conducting medical, epidemiological and health services research in Ireland. Within the HRB, a multidisciplinary team of researchers and information specialists work to provide objective, reliable and comparable information on the drug situation and its consequences and responses in Ireland. The HRB disseminates research findings, information and news in the drugs area through its Trends series, through the HRB National Drugs Library and through a quarterly research and policy bulletin, Drugnet Ireland. Through its research and dissemination activities, the HRB aims to inform policy and practice in relation to drug misuse.

Health Research Board

Grattan House, 67-72 Lower Mount Street
Dublin 2
Ireland
Tel. +353 12345168
Head of national focal point: Mr Brian Galvin

Additional resources submitted by our partner

The review analysed 10 years of data up to the most recent data available, with respect to prevalence of drug use, high risk drug use, treatment demand, drug-related deaths, and mortality and drug-related infectious diseases, as well as drug-related crime and supply. In addition to presentation of national trends, this report includes additional evidence looking at trends in data relating to specific subpopulations, including people who inject drugs, prisoners, homeless individuals, sex workers and the Traveller community.
The Irish National Focal Point commissioned the Public Health Institute at Liverpool John Moores University to prepare a report on the most recent international evidence on responses to problem drug use and a trends analysis on the drugs situation in Ireland between 2005 and 2015. The ‘review of reviews’ approach provides an overview of the most recent high-quality evidence on prevention, treatment, harm reduction and recovery.

Click here for more information about Ireland

top of page

Italy

About our partner in Italy

The Department for Anti-Drug Policies was set up at the Presidency of the Council of Ministers by means of the first decree of the President of the Council of Ministers of 20 June 2008, and placed under the functional responsibility of the Prime Ministerial Under-Secretary with delegated responsibility for drugs. The Department’s role is to promote, guide and coordinate the Government’s initiatives to combat the spread of drug and alcohol dependency and to promote cooperation with the competent public administrations in the sector, associations, therapeutic communities and other non-governmental organisations. The Italian national focal point is located in the Department, and is responsible for collecting, processing and interpreting data and information of a statistical-epidemiological, pharmacological-clinical, and psychosocial nature and for documentation on the use, abuse, dealing and trafficking of drugs and psychotropic substances. The Department is also responsible for collaboration with the European Union and international bodies operating in the sector. The national focal point is an integral part of the Department’s technical and scientific division.

Presidency of the Council of Ministers, Department for Anti-Drug Policies

Via dei Laterani n.34
I - 00184 Roma
Italy
Tel. +39 0667796350
Fax +39 0667796843
Head of national focal point: Mrs Elisabetta Simeoni

Additional resources submitted by our partner

The Annual Report to Parliament on Drugs and Addictions is the official government document prepared by the Department of Anti-Drug Policies of the Presidency of the Council of Ministers. The Report was drafted with the aim of providing a snapshot of the drug situation in Italy starting from the most recent institutional information: drug market, various dimensions of the demand for drugs, responses in terms of prevention, treatment and contrast.

Click here for more information about Italy

top of page

Latvia

About our partner in Latvia

The national focal point is located in Centre for Disease Prevention and Control of Latvia. The Centre for Disease Prevention and Control of Latvia is a newly established public institution responsible for data collection and monitoring on different public health issues.

Centre for Disease Prevention and Control of Latvia

Duntes Street 22
Rīga LV-1005
Latvia
Tel. +371 67501590
Fax.: +371 67501591
Head of national focal point: Ms Laura Isajeva

Additional resources submitted by our partner

The Centre for Disease Prevention and Control (CDPC) of Latvia – established on 1st April 2012. The Centre is supervised by the Ministry of Health. CDPC of Latvia goals are to strengthen Latvia’s public health system, prevent diseases, including infectious and rare diseases.
The Ministry of Health of the Republic of Latvia – established on 1 February 2003. The Ministry of Health is the leading government authority in the health sector and is responsible for public health, health care and pharmacy.
NGO 'Baltic HIV Association' – The aim of the association is to become a regional resource center for organizations and people working in the HIV field and to develop a cooperation network of Baltic harm reduction programs.

Click here for more information about Latvia

top of page

Lithuania

About our partner in Lithuania

The national focal point in Lithuania is situated within the Drug, Tobacco and Alcohol Control Department of the Government of the Republic of Lithuania. The main responsibilities of the department include implementation of the national drug programme, information gathering and dissemination. The department operates under the leadership of the Prime Minister and Minister of Health and is responsible for relations with international organisations, including the EMCDDA.

Drug, Tobacco and Alcohol Control Department

Sv. Stepono str. 27
LT-03212 Vilnius
Lithuania
Tel. +37 07 0663195
Fax +37 07 0668095
Head of national focal point: Ms Lina Jurgelaitiene

Additional resources submitted by our partner

Full information regarding drug related poisonings; it also receives General Mortality Registry managed by the Institute of Hygiene and collecting data from the whole country. The National focal point receives full data from the GMR and can calculate the number of drug related death cases using the standard EMCDDA DRD definition for Selection B (ICD-10) including T codes.

Click here for more information about Lithuania

top of page

Luxembourg

About our partner in Luxembourg

The headquarters of the national focal point in Luxembourg are located within the Luxembourg Institute of Health (LIH). As a scientific research institute in the field of public health, LIH is a common welfare institution, which is partly financed by the National Administration. A series of synergies between the national focal point and specialised departments of the LIH allow for effective experience sharing and management of technical, logistical and administrative activities.

Luxembourg Institute of Health, Point Focal OEDT

Logo of the Luxembourg National Focal Point

Allée Marconi - Villa Louvigny
LU-2120
Tel. +352 247 85503
Head of national focal point: Ms Nadine Berndt

Additional resources submitted by our partner

Click here for more information about Luxembourg

top of page

Malta

About our partner in Malta

The Maltese national focal point is based within the Ministry for the Family and Social Solidarity and is part of the National Coordinating Unit on Drugs and Alcohol. It started its operations in June 2004 as a result of a Twinning Light Project with the Netherlands.

National Anti-Drug Agency

Ministry for the Family and Social Solidarity
LEAP Community & Resource Centre
72, Melita Street
MT -Valletta, VLT 1120
Malta
Tel. +356 2590 3324/86/78
Head of national focal point: Mr Carlo Olivari Demanuele

Click here for more information about Malta

top of page

Netherlands

About our partner in the Netherlands

The national focal point in the Netherlands is located within the National Drug Monitor, which was established in 1999 by the Minister of Health, Welfare and Sport in order to evaluate and review registration and survey research data at the national level and to report these data to the Lower Chamber of Parliament, concerned ministries and other stakeholders both nationally and internationally. The national focal point is part of the Drug Monitoring and Policy Department of the Trimbos Institute, the national research institute for mental health care, addiction care and social work, which is tasked with informing policymakers and politicians about the mental health issues that concern the Dutch population. There is close collaboration with the Research and Documentation Centre of the Ministry of Security and Justice.

Trimbos Institute

(Netherlands Institute of Mental Health
and Addiction)
Da Costakade 45
PO Box 725
NL-3500 AS Utrecht
Netherlands
Tel. +31 302971186
Fax +31 302971187
Head of national focal point: Mrs Margriet van Laar

Additional resources submitted by our partner

The 2017 Netherlands National Report about the drug situation in The Netherlands including alcohol and tobacco and including the drug policy and the alcohol and tobacco policy by Trimbos-instituut/WODC.

Click here for more information about Netherlands

top of page

Norway

About our partner in Norway

Since 2016 the Norwegian focal point has been located in the Norwegian Institute of Public Health (FHI). FHI acts as a national competence institution for governmental authorities, the health service, the judiciary, prosecuting authorities, politicians, the media and the general public on issues related to forensic science, physical and mental health, the prevention of communicable diseases and the prevention of harmful environmental influences. It is placed directly under the Ministry of Health and Care Services.

Norwegian Institute of Public Health

Logo of Norwegian Focal Point

P.O. Box 4404 Nydalen
NO-0403 Oslo
Norway
Tel. +47 40627 424
Head of national focal point: Mr Thomas Anton Sandøy

Additional resources submitted by our partner

Click here for more information about Norway

top of page

Poland

About our partner in Poland

The Polish national focal point (Centrum Informacji o Narkotykach i Narkomanii/Information Centre for Drugs and Drug Addiction) was established in 2001 and is located within the National Bureau for Drug Prevention under the auspices of the Ministry of Health. The National Bureau for Drug Prevention is a state institution established to implement Poland’s drug policies in the drug demand reduction field. The legal basis for the national focal point and its activity is provided by a Parliamentary Act.

National Bureau for Drug Prevention

Dereniowa 52/54
PL - 02 776 Warsaw
Poland
Tel. +48 226411501
Fax +48 226411565
Head of national focal point: Mr Artur Malczewski

Additional resources submitted by our partner

The CBOS Foundation conducted the survey entitled 'Młodzież 2016' (Youth 2016). The project was first conducted in 1990. Since 2003 it has been commissioned and financed by the National Bureau for Drug Prevention. The aim of the survey is to estimate the prevalence of psychoactive substance use (including New Psychoactive Substances and medicines) among youth aged 18-19.
The book 'Monitoring and response to Drugs, Drug Addiction and New Psychoactive Substances' is a guideline for local communities on how to set up and implement local monitoring. The English part focuses on standards in drug demand and EDPQS (European standards). The NPS situations in Poland and New Zealand are also presented.

Click here for more information about Poland

top of page

Portugal

About our partner in Portugal

The Portuguese national focal point is located within the General- Directorate for Intervention on Addictive Behaviours and Dependencies (SICAD). Attached to the Ministry of Health, SICAD’s mission is to promote a reduction in the use of psychoactive substances, the prevention of addictive behaviours and a decrease in dependences. SICAD is the national focal point and is directly responsible for the implementation of the National Plan. It plans, implements and coordinates drug demand reduction interventions, and collects, analyses and disseminates information on drug use and responses to it. The Director General of SICAD is also the National Coordinator for Drugs, Drug Addiction and Alcohol-Related Problems.

Serviço de Intervenção nos
Comportamentos Aditivos e nas
Dependências

(SICAD)
Alameda das Linhas de Torres 117 (Parque de
Saúde Pulido Valente)
Edificio SICAD
1750-147 Lisboa
Portugal
Tel. +351 211119000
Fax +351 211112790 to 98
Head of national focal point: Mrs Ana Sofia Santos

 

Additional resources submitted by our partner

National portal of the Focal Point. The Service of Intervention in Addictive Behaviors and Dependencies (SICAD) is to promote the reduction of the consumption of psychoactive substances, the prevention of addictive behaviors and the reduction of addictions.
Published research, studies and statistics from the Service of Intervention in Addictive Behaviors and Dependencies (SICAD)

Click here for more information about Portugal

top of page

Romania

About our partner in Romania

The Romanian national focal point is a unit within the National Anti-Drug Agency under the remit of the Ministry of Internal Affairs. The director of the Agency acts as the national coordinator on drugs in Romania. The director is responsible for coordinating the drafting of the national drugs strategy and related action plans and acts for their application. The director also has the responsibility of ensuring compliance with the international conventions and agreements to which Romania is party and proposes to the Government, through the Ministry of Internal Affairs, measures regarding the fulfilment of the obligations arising from these international documents.

National Anti-Drug Agency

37th Unirii Boulevard, Bl. A4
3rd District
RO-Bucharest
Romania
Tel. +40 213164797
Fax +40 213164797
Head of national focal point: Ms Ruxanda Iliescu
 

Click here for more information about Romania

top of page

Slovakia

About our partner in Slovakia

The national focal point is located within the Department of Drug Strategy Coordination and Monitoring of Drugs, which is based within the Ministry of Health. Under the responsibility of the Health Ministry’s State Secretary, the Department functions as an executive body/secretariat of the Government Council for Drug Policy and oversees the coordination and implementation of the national drugs strategy. The Department’s Director is also the Secretary of the Council and ex officio National Drug Coordinator. The department consists of two sections. The National Drugs Strategy section is tasked with national coordination and implementation of the National Anti-Drugs Strategy. It also contains a unit dealing with institutional and international relations and information transfers related to drug issues. The National Monitoring Centre for Drugs section functions as Slovakia’s national focal point to the EMCDDA. It is responsible for monitoring of the drug situation and managing national drug information systems.

National Monitoring Centre for Drugs

Ministry of Health of the Slovak Republic
(Národné monitorovacie centrum
pre drogy, Ministerstvo zdravotníctva
Slovenskej republiky)
Limbova 2, P.O. Box 52
SK-83752 Bratislava
Slovakia
Tel. +421 259373167
Fax +421 257295819
Head of national focal point: Mr Imrich Steliar

Click here for more information about Slovakia

top of page

Slovenia

About our partner in Slovenia

The Slovenian national focal point is a part of the Information Unit for Illicit Drugs (IUID), which is located at the National Institute of Public Health of the Republic of Slovenia (NIPH). The NIPH collects, organises and analyses health-related statistical data in the fields of diagnoses, attendance, staff and visiting hours in outpatient facilities, outpatient specialist services and hospitals. The legal basis for the establishment of the Slovenian national focal point is the Prevention of Illicit Drug Abuse and Treatment of Drug Addictions Act (1999).

National Institute of Public Health

Trubarjeva 2
SI-1000 Ljubljana
Slovenia
Tel. +386 12441400
Fax +386 12441447
Head of national focal point: Mr Milan Krek

 

Additional resources submitted by our partner

Click here for more information about Slovenia

top of page

Spain

About our partner in Spain

The Spanish national focal point is located within the Government Delegation for the National Plan on Drugs, a government organisation under the auspices of the Ministry of Health, Consumer Affairs and Welfare. The Government Delegation for the National Plan on Drugs is entrusted with coordination of different aspects of drug policy, ranging from drug trafficking to responses to the drug problem.

Government Delegation for National Plan on Drugs (Delegación del Gobierno para el Plan Nacional sobre Drogas)

Plaza de España, 17
E-28008 Madrid
Spain
Tel. +34 91 822 61 25
Fax +34 91 822 60 95
Head of national focal point: María Azucena Martí Palacios

Additional resources submitted by our partner

Main and most relevant data of the information included in the 2017 Report on Alcohol, Tobacco and Illegal Drugs in Spain under the following paragraphs: Survey on alcohol and drugs, Survey on drug use in Secondary Education, Treatment for drug use, Hospital emergencies in drug users, Infections in drug users, Mortality related to drugs and Spanish Early Warning System. This information should help policy makers, and other stake holders to make decisions on these issues in their respective fields and to develop and evaluate programs and interventions aimed at preventing and reducing the consumption of drugs and associated problems, as well as to face other addictions without substance (English version).
Contains the complete Report on Alcohol, Tobacco and Illegal Drugs in Spain, grouped in the following epigraphs: Survey on alcohol and drugs in Spain (AGES), Survey on drug use in Secondary Education in Spain (STUDIES), Treatment for drug use, Hospital emergencies in drug users, Infections in drug users, Mortality related to drugs, Spanish Early Warning System (SEAT). This information should help policy makers, and other stake holders to make decisions on these issues in their respective fields and to develop and evaluate programs and interventions aimed at preventing and reducing the consumption of drugs and associated problems, as well as to face other addictions without substance.
This document complements the Alcohol, tobacco and illegal drugs in Spain 2017 Report, with a selection of tables and figures. In chapter 1, information is presented regarding the consumption, perceptions and opinions of the population regarding drugs from 1995 to 2015. The source of information is the Alcohol and Drug Surveys in Spain (EDADES), in its successive editions. In chapter 2, information of drug-related problems from 1987 to 2015 is included. The information comes from three key indicators: 'Admissions to treatment for consumption of psychoactive substances', 'Hospital emergencies in consumers of psychoactive substances' and 'Mortality by acute reaction to psychoactive substances'.
Contains the results of the EPAD, Survey for teachers of Secondary Education, on Drugs and other Addictions in Spain. The objective is to know the perceptions and opinions of the teachers of Secondary Education on different aspects related to the consumption of drugs and other addictions. Young people are one of the most exposed to the use of psychoactive substances and their attitudes and behaviors regarding consumption change fairly quickly. Consequently, it is important to have regular and updated information on these phenomena to develop and evaluate programs and interventions aimed at reducing consumption and associated problems in a rational way.
The results of the Evaluation of the Strategy by objectives and the degree of achievement of its general objectives are collected. The objectives evaluated are: - Optimize coordination and cooperation. - Promote a social awareness about risks and damages. - Increase personal skills and abilities. - Delay the age of onset of consumption . - Decrease consumption. - Reduce the associated damages. - Guarantee quality assistance. - Facilitate social incorporation. - Increase the effectiveness of supply control. - Increase money laundering control mechanisms. - Improve research. - Enhance the evaluation of programs. - Improve training. - Optimize international cooperation. - Objectives related to the Guiding Principles. From each of these objectives information has been collected through a set of indicators.The impact of the Strategy has been also evaluated as well as the financing of it. The Evaluation also contains Conclusions and Final Recommendations
The National Strategy on Addictions 2017-2024 is the result of the consensus among numerous stakeholders that is offered as the framework for the development of policies on addictions. The Strategy foresees two major goals: to achieve a healthier and more informed society and to achieve a safer society. It covers legal drugs (tobacco and alcohol) prescribed medicines, illegal substances and addictions without substance The transversal areas of action of this Strategy include: a) coordination, b) knowledge management (information systems, research and training, c) legislation, d) international cooperation, e) communication and dissemination, and f) evaluation and the quality. The scientific evidence available on addictions has been reviewed, especially the one related to the role of new technologies as facilitators of access to and enhancers of certain addictive behaviors.

Click here for more information about Spain

top of page

Sweden

About our partner in Sweden

The Swedish national focal point is located within the Public Health Agency of Sweden, which is responsible for national public health issues. The agency promotes good public health by building and disseminating knowledge to healthcare professionals and others responsible for infectious disease control and public health.

Public Health Agency of Sweden

(Folkhälsomyndigheten)
Forskarens väg 3
S-831 40 Östersund
Sweden
Tel. +46 10 205 29 08
Head of national focal point: Mr Joakim Strandberg
 

Click here for more information about Sweden

top of page

Turkey

About our partner in Turkey

The Turkish Monitoring Centre for Drugs and Drug Addiction (TUBİM) is attached to the Ministry of Interior/Turkish National Police/ Counter Narcotics Department. It is responsible for the coordination and implementation of the national drug strategy on behalf of the Ministry of Interior and for monitoring the drug situation in the whole country. It does this through its network of provincial focal points around the country. TUBİM also manages Turkey’s National Early Warning System for monitoring new psychoactive substances. Comprised of academics from a range of disciplines, TUBİM’s Scientific Committee reviews evidence that is related to drug policy issues and provides advice to the government.

Turkish Monitoring Centre for Drugs and Drug Addiction (Türkiye Uyuşturucu ve Uyuşturucu Bağımlılığı İzleme Merkezi)

EMCDDA Türkiye Ulusal Temas Noktası
Meşrutiyet Mah. Konur Sokak No:40
TR-06640 Çankaya/Ankara
Turkey
Tel. +90 312 462 8050-55
Fax: +90 312 462 8059
Head of national focal point: Mr Murat Sarigüzel

Click here for more information about Turkey

top of page

United-Kingdom

 

About our partner in the United Kingdom

The UK Focal Point on Drugs (the national focal point) is based in Public Health England. It works closely with the Home Office, other government departments and the devolved administrations (Northern Ireland, Scotland and Wales) in providing information to the EMCDDA.

UK Focal Point on Drugs, Public Health England

Skipton House
80 London Road
London, SE1 6LH
United Kingdom
Tel. +44 20 3682 0543
Email: UKfocalpoint@phe.gov.uk
Head of national focal point: Ms Catherine Crawford

Click here for more information about United-Kingdom

top of page

Loading